RE: RNS : H1 results and Investor meet co on 29/09/2215 Sep 2022 12:21
If we enter questions ensuring that one of them was the same from each poster on this board,
we could ensure DA had received one popular question from shareholders.
"Why are you spending so much time and money in R&D projects, when you do not share what those projects mean to our bottom line. In what ways are we better off having developed them.
If you are White labelling, give some non-specific indication of that, else we are entitled to think you come to work to chill."
That's not a good question to send in, but posters should consider sending in their best attempt and we'll vote for joe and all send the winning question in.
+++
It would be interesting to know FROM THE COMPANY why CLONIT (Milan) on linkedin is being liked by NCYT staff and management.
Haven't bothered asking Mandy, - I've asked similar and got no response.
+++
As at 14.09.2022 -
Monkeypox liked by NCYT staff.
Tropical Infections Real-time PCR Panel liked by NCYT staff.
POCT FIC-Q100N Dry Fluorescent Immunoanalyzer system liked by NCYT staff.
West Nile Virus liked by NCYT staff.
Tick Borne Diseases Not Liked by NCYT staff.
Covid-19 HT Screen / Screen 501 Liked by NCYT staff.
There may be other CLONIT products liked by staff.